In 1929, Dr. John Ralston Davidson from
Canada discovered a way to extract the life essence from a nine-day old
Fertilized Avian Egg. It was later dubbed as “Young Tissue Extract” by another
egg researcher, Dr. Bjodne Eskeland, who took on the discovery some 50 years
later.
After studying at Johns Hopkins
University, Dr. Davidson returned to practice medicine in Winnipeg. The
discovery of Dr. Davidson was highly controversial. The treatment for cancer
involving a high-vitamin diet even became a subject of the House of Commons
debate in 1944.
His treatment was subsequently
investigated by a four-man medical commission appointed by the province later
in 1944, which discounted its efficacy. Unfortunately, Davidson died on April
15, 1948, and his research and development rested for decades. (Source – History of Laminine - https://www.altheadistributor.com/laminine-history/)
Although Dr. Davidson and Dr. Eskeland
never met, their contribution in egg research is shaping how scientists
understand the benefits from taking Fertilized Avian Egg Extract that contains FibroBlast Growth Factor or FGF.
Dr. Eskeland is known as the ‘Founder of
Young Tissue Extract’ or YTE. He
hypothesized that fertilized avian eggs contained a special combination of
amino acids, peptides and protein fractions that could help provide an
incredible array of health benefits when consumed by humans.
This included vitamins, minerals, and
proteins, as well as important defense elements, growth factors, hormones and
other biologically active components.
The extract is known today as Laminine which was first marketed in
the USA, then to the rest of the
world beginning in Canada, Australia, the UK, Philippines, and soon
inSingapore.
Laminine has positive effect on memory
focus, skin, libido, energy, joints, muscles, stress, sleep and emotional
stability.
It boasts of benefits supported by clinical studies. This includes, the
supports for faster wound healing, reduces stress, positive effect on blood sugar
levels, cholesterol, triglyceride, and uric acid.
No comments:
Post a Comment